| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 25,538 | 25,707 | 25,612 | 26,638 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 25,707 | 25,612 | 26,638 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,840 | 25,063 | 24,584 | 24,581 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 6,848 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,244) | 644 | 1,028 | 2,057 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (3,995) | | Earnings Before Interest And Taxes | 850 | 644 | 1,028 | (1,938) | | Interest Expense | 679 | 694 | 721 | 781 | | Income Before Tax | 171 | (50) | 307 | (2,719) | | Income Tax Expense | 2,279 | (62) | 51 | (1,210) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,108) | 12 | 256 | (1,509) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (1,251) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,108) | 12 | 256 | (2,760) | | Preferred Stock And Other Adjustments | (127) | (127) | (127) | (243) | | | Net Income Applicable To Common Shares | ($2,235) | ($115) | $129 | ($3,003) |
|
0.03% Nasdaq 
Income Statement
